| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/2002 | EP1220612A1 Pediculocidal and veterinary compositions |
| 07/10/2002 | EP1140786A4 Reductive alkylation of secondary amines with hydrosilane |
| 07/10/2002 | EP1115420B1 Treatment of hepatitis b infection with thymosin alpha 1 and lamivudine |
| 07/10/2002 | EP1098657B1 Green tea extracts containing catechols and caffeine |
| 07/10/2002 | EP1071410B1 Ionic aqueous composition containing levomenthol |
| 07/10/2002 | EP0973793B1 Novel 4- halogenated steroids, preparation method and intermediates, application as medicines and pharmaceutical compositions containing same |
| 07/10/2002 | EP0970130B1 Glycosaminoglycans having high antithrombotic activity |
| 07/10/2002 | EP0967967B1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 07/10/2002 | EP0952975B1 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 07/10/2002 | EP0938339B1 Formulations for topical use containing vit. e acetate |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0820322B1 Metered dose inhaler for fluticasone propionate |
| 07/10/2002 | EP0819128B1 Tricyclic compounds useful in the treatment of cell proliferative disorders |
| 07/10/2002 | EP0812319B1 2-arylbenzazole compounds |
| 07/10/2002 | EP0738148B1 Self-assembled taxo-diperpenoid nanostructures |
| 07/10/2002 | EP0690862B1 Quinolone derivatives and processes for preparing the same |
| 07/10/2002 | EP0517852B1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358191A N-pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358190A Propargyl phenyl ether A2A receptor agonists |
| 07/10/2002 | CN1358189A C-2A pyrazole A2A receptor agonists |
| 07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
| 07/10/2002 | CN1358187A New compounds |
| 07/10/2002 | CN1358185A Optically active quinoline carboxylic acid derivatives having T-pyrrolidine substues causing optical activity and process for preparing thereof |
| 07/10/2002 | CN1358184A 新药物 New Drug |
| 07/10/2002 | CN1358183A Quinolinecarboxylic acid derivative or salts thereof |
| 07/10/2002 | CN1358182A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358181A 呼吸道合胞病毒复制抑制剂 Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358180A Respiratory syncytial virus replication inhibitors |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358178A Pharmaceutical compounds |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358174A New Compounds |
| 07/10/2002 | CN1358172A Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/10/2002 | CN1358104A Low dose estrogen interupted hormone replacement therapy |
| 07/10/2002 | CN1358102A Preventives/remedies for angiostenosis |
| 07/10/2002 | CN1358099A Utilization of aminopeptidase inhibitor |
| 07/10/2002 | CN1358097A Anionic polymers as toxin binders and antibacterial agents |
| 07/10/2002 | CN1358096A Remedies for diabetes |
| 07/10/2002 | CN1358095A Method for treating chronic pain uisng MEK inhibitors |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358093A Decursinol or derivative thereof as analgesic agent |
| 07/10/2002 | CN1358092A Pharmaceutical composition containing sibutramine and orlistat |
| 07/10/2002 | CN1358091A Estrogen receptor-beta ligands |
| 07/10/2002 | CN1358090A Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 07/10/2002 | CN1358089A Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/10/2002 | CN1358087A Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 07/10/2002 | CN1358086A Ophthalmic composition comprising retotifen |
| 07/10/2002 | CN1358062A 巨噬细胞清除剂受体拮抗剂 Macrophage scavenger receptor antagonists |
| 07/10/2002 | CN1357358A Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process |
| 07/10/2002 | CN1357346A Osteoporosis treaitng medicine comprising effective components extracted from Chinese medicinal material |
| 07/10/2002 | CN1357332A Application of double-stranded ribonucleic acid in prepairng medicine for treaitng hepatic tumor and hepatitis B |
| 07/10/2002 | CN1357331A Suppository for controlling sexual spread of AIDS |
| 07/10/2002 | CN1357330A Externally-applied medicine for treating dermatosis |
| 07/10/2002 | CN1357329A Medicine for treating perennial allergic rhinitis |
| 07/10/2002 | CN1357328A Medicine preparation and its production process |
| 07/10/2002 | CN1357327A Carbazolyl alkaloid anticarcinogen and its prepn |
| 07/10/2002 | CN1357326A Composition containing calcium ascorbate and calcium L-threonate |
| 07/10/2002 | CN1357325A Prepn of natural active body cell multiplication promoter |
| 07/10/2002 | CN1357324A Loselofen sodium injection and its prepn |
| 07/10/2002 | CN1357323A New application of threonic acid and its salt |
| 07/10/2002 | CN1357322A Bioenergy muscle relexant |
| 07/10/2002 | CN1357321A Inflammation and red spot reducing method |
| 07/10/2002 | CN1357311A Medical application of ursolic acid |
| 07/10/2002 | CN1357230A Antibacterial composition diffused to resist bacteria in the air and its diffision method |
| 07/10/2002 | CN1087350C Process for enzymatic synthesis of beta-lactam antibiotics in pressence of enzyme inhibitor |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087294C Novel compounds |
| 07/10/2002 | CN1087291C N-hydroxyureas as antiiflammatory agents |
| 07/10/2002 | CN1087290C 4-aminotetrahydrobenzisoxazole or-isothiazole compounds |
| 07/10/2002 | CN1087289C Novel process for the production of amorphous [R-(R,R.)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt |
| 07/10/2002 | CN1087288C Crystalline [R-(R+,R+)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl]-1H-pyrole-1-heptanoic acid hemi-calcium salt (atorvastatin) |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/10/2002 | CN1087283C New LH-RH antigonists with improved effectiveness |
| 07/10/2002 | CN1087178C Isotopic urea tablets |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/10/2002 | CN1087170C Medical composition for prevention of early pregnancy |
| 07/10/2002 | CN1087169C Anti-inflammatory eyedrops |
| 07/10/2002 | CN1087168C Compound with cooperation of anti-malaria |
| 07/09/2002 | US6417394 Specific salt forms of triphenylethylene derivatives as selective estrogen receptor modulators |
| 07/09/2002 | US6417393 Treatment of sickle-cell anemia, brain edema from tumors or ischemia, diarrhea, and glaucoma; hypotensive, wound healing, antiinflammatory and antiallergen agents |
| 07/09/2002 | US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417360 Heterocyclic sulfonamides |
| 07/09/2002 | US6417359 Pharmaceutical compositions and methods for use |
| 07/09/2002 | US6417352 Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid |
| 07/09/2002 | US6417349 Water-soluble extract of asiaticoside and madecassoside from Centella asiatica and isolating method thereof |
| 07/09/2002 | US6417339 Core, spacers |
| 07/09/2002 | US6417236 Active topical skin protectants using hybrid organic polysilsesquioxane materials |
| 07/09/2002 | US6417235 Method and use of α-amino-β-mercapto-ethane derivatives as dicarbonyl scavengers for treatment of conditions resulting from protein, lipid, and DNA damage |
| 07/09/2002 | US6417234 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 07/09/2002 | US6417233 Benzoquinone coenzyme q10 |
| 07/09/2002 | US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis |
| 07/09/2002 | US6417231 Method and composition for delivering therapeutically effective amounts of pyruvate to a mammal |
| 07/09/2002 | US6417230 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| 07/09/2002 | US6417229 Enzyme inhibitors |
| 07/09/2002 | US6417228 Treatment of glaucoma and hypotensive agents |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417226 Contain alph-hydroxytetronic acid or a derivative, and, in some cases, hydroquinone, an alpha -hydroxy acid such as glycolic acid, and a fatty acid ester of ascorbic acid such as ascorbyl palmitate. |